Postponement of Board Meeting
With reference to the earlier announcement dated April 23, 2013, regarding a meeting of the Board of Directors of the Company will be held on May 03, 2013, inter alia, to consider & take on record the Audited Financial results for the year and quarter ended March 31, 2013, and to recommend dividend, if any, thereon, Pfizer Ltd has now informed BSE that due to delay in finalization of accounts and completion of audit, the said Board Meeting has been... Board to consider Dividend
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 03, 2013, inter alia, to consider and take on record the Audited Financial Results for the quarter January 01, 2013 to March 31, 2013 and the year ended March 31, 2013.At the said meeting, the Board of Directors will also consider recommendation of Dividend, if any, for the year ended March 31, 2013. Financial Results & Limited Review for Dec 31, 2012
Pfizer Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2012. Resignation of Director
Pfizer Ltd has informed BSE that Mr Sunil Madhok, Executive Director, Business Operations has retired from the services of the Company with effect from January 31, 2013 and has also resigned from the Board of effective the said date.The Board of Directors of the Company at its meeting held on February 07, 2013 has accepted the resignation of Mr Sunil Madhok with effect from close of business on January 31, 2013. Pfizer Ltd completes the sale of its wholly owned subsidiary Pfizer Animal Pharma Private Limited to Pfizer Animal Health India Limited
Pfizer Ltd has informed BSE regarding "Pfizer Ltd completes the sale of its wholly owned subsidiary Pfizer Animal Pharma Private Limited to Pfizer Animal Health India Limited." Outcome of Board Meeting
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 08, 2012, has approved, subject to receipt of prior regulatory approvals, the sale of its wholly owned subsidiary Pfizer Animal Pharma Private Limited to Pfizer Animal Health India Limited, a 100% indirect subsidiary of Pfizer Inc., USA for a consideration of Rs. 471.60 Crores (Rupees Four Hundred and Seventy One Crores and Sixty Lakhs only). Financial Results & Limited Review for Sep 30, 2012
Pfizer Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2012. Updates on Outcome of AGM
Pfizer Ltd has submitted to BSE a copy of Minutes of the 61st Annual General Meeting (AGM) of the Company was held on August 02, 2012. (For more details kindly refer Corporate Announcements on www.bseindia.com). Financial Results & Limited Review for June 30, 2012
Pfizer Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2012. Disclosure of Voting Results of AGM (Clause 35A)
Pfizer Ltd has informed BSE that the Annual General Meeting (AGM) of the Company was held on August 02, 2012, under Clause 35A. (For more details kindly refer Corporate Announcements on www.bseindia.com).